This browser is not supported, please use a modern browser!

New genetic etiology in teenage-onset colorectal cancer identified

Medicover Genetics Editorial Team |
September 28, 2022

Colorectal cancer (CRC) in adolescents and young adults (AYA) is rare. Genetic causes include autosomal recessive and dominant monogenic disorders due to pathogenic variants (PVs) in genes involved in DNA repair. However, the genetic etiology of the majority of AYA-CRC remains unidentified. In two teenage siblings with CRC, we show to our knowledge for the first time that AYA-CRC cases can be caused by digenic inheritance of each a heterozygous pathogenic variant (PV) in the mismatch-repair (MMR) gene PMS2 and the proofreading polymerase (PP) Pol δ gene POLD1. With the aim to elucidate how the constitutional polymerase proofreading defect and the high propensity to MMR deficiency (MMRd) interact, we performed a comprehensive tumor analysis of the two siblings’ tumors. Results indicate that tumorigenesis is initiated by MMRd and the inherited POLD1 PV contributes to fast tumor progression reflected by an ultra-high tumor mutational burden (TMB) and specific mutational signatures.

Abstract

Colorectal cancer (CRC) in adolescents and young adults (AYA) is very rare. Known predisposition syndromes include Lynch syndrome (LS) due to highly penetrant MLH1 and MSH2 alleles, familial adenomatous polyposis (FAP), constitutional mismatch-repair deficiency (CMMRD), and polymerase proofreading-associated polyposis (PPAP). Yet, 60% of AYA-CRC cases remain unexplained. In two teenage siblings with multiple adenomas and CRC, we identified a maternally inherited heterozygous PMS2 exon 12 deletion, NM_000535.7:c.2007-786_2174+493del1447, and a paternally inherited POLD1 variant, NP_002682.2:p.Asp316Asn. Comprehensive molecular tumor analysis revealed ultra-mutation (>100 Mut/Mb) and a large contribution of COSMIC signature SBS20 in both siblings’ CRCs, confirming their predisposition to AYA-CRC results from a high propensity for somatic MMR deficiency (MMRd) compounded by a constitutional Pol δ proofreading defect. COSMIC signature SBS20 as well as SBS26 in the index patient’s CRC were associated with an early mutation burst, suggesting MMRd was an early event in tumorigenesis. The somatic second hits in PMS2 were through loss of heterozygosity (LOH) in both tumors, suggesting PPd-independent acquisition of MMRd. Taken together, these patients represent the first cases of cancer predisposition due to heterozygous variants in PMS2 and POLD1. Analysis of their CRCs supports that POLD1-mutated tumors acquire hypermutation only with concurrent MMRd.

Reference

Schamschula E, Kinzel M, Wernstedt A, Oberhuber K, Gottschling H, Schnaiter S, Friedrichs N, Merkelbach-Bruse S, Zschocke J, Gallon R, Wimmer K. Teenage-Onset Colorectal Cancers in a Digenic Cancer Predisposition Syndrome Provide Clues for the Interaction between Mismatch Repair and Polymerase δ Proofreading Deficiency in Tumorigenesis. Biomolecules. 2022; 12(10):1350. https://doi.org/10.3390/biom12101350

Related articles

Carrier screening: A comprehensive guide to genetic health and reproductive planning

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inhe..

Trisomy awareness month: Understanding trisomy 13

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of t..

Genetic Testing: A powerful tool in the fight against cardiovascular diseases

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsib..

Related articles

Carrier screening: A comprehensive guide to genetic health and reproductive planning

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inhe..

Trisomy awareness month: Understanding trisomy 13

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of t..

Genetic Testing: A powerful tool in the fight against cardiovascular diseases

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsib..

Latest articles

10 facts about DNA

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics...

Genetic causes of neurodevelopmental disorders: Insights from trio exome sequencing

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric ..

Newly published study demonstrates insights in anti-EGFR re-challenge and the role of liquid biopsy in metastatic colorectal cancer

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an..

Latest articles

10 facts about DNA

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics...

Genetic causes of neurodevelopmental disorders: Insights from trio exome sequencing

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric ..

Newly published study demonstrates insights in anti-EGFR re-challenge and the role of liquid biopsy in metastatic colorectal cancer

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an..

RELATED PRODUCTS

HEREDITARY CANCER PANELS PREDICT&PREVENT

Estimating cancer risks using clinically actionable gene panels

COLON CANCER CORE PANEL

The Core Panel contains genes found in 5% of cases, including the DNA mismatch repair genes which are found in other cancers as well

COMPREHENSIVE HEREDITARY CANCER PANEL

The comprehensive cancer panel analyses 54 genes associated with >30 cancer types spanning across 10 organs and systems including breast, ovary, colon, endocrine system, pancreas, stomach, prostate, skin, kidney and nervous system/brain.

OUR NETWORK

Exit mobile version